MedPath

COLLAWELL® NevWell Advance Capsule

Registration Number: MAL24116089NC

Approved
Approval ID

f683e4c0c0952b18

Registration Number

MAL24116089NC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types6 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (6)

30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
90 CapsulesAvailable
Package Size: 90 Capsules
Status: NPRA Approved
120 CapsulesAvailable
Package Size: 120 Capsules
Status: NPRA Approved
150 CapsulesAvailable
Package Size: 150 Capsules
Status: NPRA Approved
180 CapsulesAvailable
Package Size: 180 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (9)

ALPHA LIPOIC ACIDActive
Monograph: 硫辛酸
PYRIDOXINE HYDROCHLORIDEActive
Monograph: 维生素B6
Vitamin D3 (Cholecalciferol)Active
Monograph: vitamin d 3 (cholecalciferol)
DL-ALPHA TOCOPHERYL ACETATEActive
INOSITOLActive
Monograph: 肌醇
BENFOTIAMINEActive
Monograph: 苯磷硫胺
METHYLCOBALAMINActive
Monograph: 甲钴胺
D-CALCIUM PANTOTHENATEActive
Monograph: d-calcium pantothenate
CHROMIUM POLYNICOTINATEActive
Monograph: chromium polynicotinate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

COLLAWELL® NevWell Advance Capsule - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform